CFR /  Title 21  /  Part 314  /  Sec. 314.630 Postmarketing safety reporting.

Drug products approved under this subpart are subject to the postmarketing recordkeeping and safety reporting requirements applicable to all approved drug products, as provided in Sec. Sec. 314.80 and 314.81.